Refract Ventures
Overview
Refract Ventures is a New York-based venture capital investment firm that invests in early-stage companies, focusing on software infrastructure for healthcare and financial services, as well as regulated industries, biotech, applied AI, and consumer platforms.
Portfolio Companies
7
Website
refract.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Charta Health | Jul 2025 | Series A | Co-investor |
| Sage Care | Oct 2025 | Series A | Co-investor |
| Prax Health | Mar 2026 | Seed | Co-investor |
| Brale | Sep 2025 | Series A | Co-investor |
| YouShift | Feb 2025 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Key People
Ayokunle Omojola
Co-founder & GP
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Refract Ventures based?
Refract Ventures is headquartered in New York City, New York, United States.
When was Refract Ventures founded?
Founding year information for Refract Ventures is not publicly available.
How many portfolio companies does Refract Ventures have?
Refract Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Refract Ventures's portfolio?
Portfolio companies visible on Caplight include Charta Health, Sage Care, Prax Health, Brale, YouShift.
What was Refract Ventures's most recent investment shown here?
Refract Ventures's most recent investment in this portfolio sample was in Prax Health in 2026.
What sectors does Refract Ventures focus on?
Refract Ventures focuses on Healthcare & Life Sciences, Crypto & Web3, FinTech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, FinTech, Enterprise Software, Crypto & Web3.
What company stages does Refract Ventures focus on?
Refract Ventures typically invests at the Early stage.
What is Refract Ventures's AUM?
Refract Ventures's assets under management are estimated between $30.0M and $30.0M.